Related references
Note: Only part of the references are listed.Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study
Romain Colle et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine
Yu Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder
Masashi Sakurai et al.
SCIENTIFIC REPORTS (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Power and Sample Size Calculations for Genetic Association Studies in the Presence of Genetic Model Misspecification
Camille M. Moore et al.
HUMAN HEREDITY (2020)
Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies
Na Cai et al.
HUMAN MOLECULAR GENETICS (2020)
Genome-wide association studies of antidepressant class response and treatment-resistant depression
Qingqin S. Li et al.
TRANSLATIONAL PSYCHIATRY (2020)
Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
Ankit Srivastava et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Plasma serotonin levels are associated with antidepressant response to SSRIs
Amanda Holck et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review
Erik Hoglund et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
Sudeepa Bhattacharyya et al.
TRANSLATIONAL PSYCHIATRY (2019)
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples
Chiara Fabbri et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Mechanisms of clathrin-mediated endocytosis
Marko Kaksonen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
Duan Liu et al.
TRANSLATIONAL PSYCHIATRY (2018)
A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog
Joannella Morales et al.
GENOME BIOLOGY (2018)
Commentary: What is the case for candidate gene approaches in the era of high-throughput genomics? A response to Border and Keller (2017)
Sarah R. Moore
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2017)
Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study
Boadie W. Dunlop et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
M. Gupta et al.
MOLECULAR PSYCHIATRY (2016)
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
Gael Qesseveur et al.
NEUROPHARMACOLOGY (2016)
Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models
Raymond Noordam et al.
PHARMACOGENOMICS (2016)
Depression sum-scores don't add up: why analyzing specific depression symptoms is essential
Eiko I. Fried et al.
BMC MEDICINE (2015)
Brain-derived neurotrophic factor Va166Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients
Romain Colle et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Fitting Linear Mixed-Effects Models Using lme4
Douglas Bates et al.
JOURNAL OF STATISTICAL SOFTWARE (2015)
BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients
Romain Colle et al.
PHARMACOGENOMICS (2015)
Genome-wide association studies in pharmacogenomics of antidepressants
Eugene Lin et al.
PHARMACOGENOMICS (2015)
Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort
Emmanuelle Corruble et al.
WORLD PSYCHIATRY (2015)
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
Brenda W. J. H. Penninx et al.
BMC MEDICINE (2013)
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
Harvey T. McMahon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Growth Modeling With Nonignorable Dropout: Alternative Analyses of the STAR*D Antidepressant Trial
Bengt Muthen et al.
PSYCHOLOGICAL METHODS (2011)
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Gonzalo Laje et al.
PSYCHIATRIC SERVICES (2009)
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression
Madhukar H. Trivedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Environmental and genetic factors associated with morphine response in the postoperative period
L Coulbault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Influence of the sample preparation method on the serotonin determination in plasma and platelets
MT Morgadinho et al.
BIOMEDICAL CHROMATOGRAPHY (2004)
Share Paper
